About Protalix

We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx^®protein expression system.More

Patients

Protalix is developing therapies that may potentially address Gaucher disease, Fabry disease, biodefense indications, and autoimmune disease (including rheumatoid arthritis). More